Menu Search
Equities

Roche Holding AG

  • Add to watchlist
  • Add to portfolio
  • Add an alert
RHO:BRN

Roche Holding AG

Actions
  • Price (CHF)363.05
  • Today's Change-3.38 / -0.92%
  • Shares traded26.00
  • 1 Year change+17.57%
  • Beta1.0093
Data delayed at least 15 minutes, as of Feb 09 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

  • Revenue in CHF (TTM)61.52bn
  • Net income in CHF12.88bn
  • Incorporated1966
  • Employees112.77k
  • Location
    Roche Holding AGGrenzacherstrasse 124BASEL 4002SwitzerlandCHE
  • Phone+41 616881111
  • Websitehttps://www.roche.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		ROG:SWX since
announced		Transaction
value
89bio IncDeal completed18 Sep 202518 Sep 2025Deal completed34.49%3.19bn
Data delayed at least 15 minutes, as of Feb 10 2026 16:16 GMT.

Institutional shareholders

8.33%Per cent of shares held by top holders
HolderShares% Held
Canada Pension Plan Investment Boardas of 31 Mar 20241.92m1.80%
APG Asset Management NVas of 31 Dec 20241.85m1.74%
UBS Asset Management Switzerland AGas of 06 Jan 20261.43m1.34%
The Vanguard Group, Inc.as of 07 Jan 20261.15m1.08%
BlackRock Fund Advisorsas of 09 Jan 2026759.96k0.71%
Z�rcher Kantonalbank (Investment Management)as of 31 Dec 2025568.55k0.53%
Geode Capital Management LLCas of 05 Feb 2026359.41k0.34%
BlackRock Investment Management (UK) Ltd.as of 06 Feb 2026310.29k0.29%
BlackRock Advisors (UK) Ltd.as of 09 Jan 2026309.49k0.29%
Vontobel Asset Management AGas of 31 Dec 2025224.24k0.21%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.